1375471-83-2 Usage
Uses
Used in Pharmaceutical Industry:
[(endo)-8-tert-butoxycarbonyl-8-azabicyclo[3.2.1]octan-3-yl]acetic acid is used as a precursor for the synthesis of various drugs, making it a valuable component in the development of new pharmaceuticals.
Used in Organic Synthesis:
[(endo)-8-tert-butoxycarbonyl-8-azabicyclo[3.2.1]octan-3-yl]acetic acid serves as a building block in organic synthesis, allowing for the creation of a wide range of pharmacologically active molecules.
Used in Medicinal Chemistry:
Due to its unique structure and functional groups, [(endo)-8-tert-butoxycarbonyl-8-azabicyclo[3.2.1]octan-3-yl]acetic acid has potential applications in medicinal chemistry, where it can be utilized in the design and synthesis of novel therapeutic agents.
Used in Drug Discovery Research:
[(endo)-8-tert-butoxycarbonyl-8-azabicyclo[3.2.1]octan-3-yl]acetic acid's properties also make it a promising candidate for drug discovery research, where it can be explored for its potential to contribute to the development of new medications and treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1375471-83-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,5,4,7 and 1 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1375471-83:
(9*1)+(8*3)+(7*7)+(6*5)+(5*4)+(4*7)+(3*1)+(2*8)+(1*3)=182
182 % 10 = 2
So 1375471-83-2 is a valid CAS Registry Number.
1375471-83-2Relevant academic research and scientific papers
SUBSTITUTED TROPANE DERIVATIVES
-
Paragraph 0101, (2017/04/12)
Provided is a compound which is useful as a prophylactic or therapeutic agent for various diseases in which T-type calcium channels are involved, such as hypertension, arrhythmia, pain and cancers, the compound having antagonistic activity against T-type
ATX MODULATING AGENTS
-
Page/Page column 100; 101, (2015/12/24)
Compounds of formula (I) can modulate the activity of autotaxin (ATX).
BICYCLIC NITROGEN COMPOUNDS AS MODULATORS OF GHRELIN RECEPTOR AND USES THEREOF
-
Page/Page column 107, (2010/11/28)
Disclosed herein are compounds of Formula I as defined herein, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, that modulates the activity of a ghrelin receptor. Disclosed herein are also methods of treating diseases or conditions that comprise administering to a subject in need thereof a therapeutically effective amount of a compound of Formula I.
